Literature DB >> 2409956

Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture.

J H Campbell, M F Reardon, G R Campbell, P J Nestel.   

Abstract

Smooth muscle cells of the rabbit aorta, when grown in vitro, express three distinguishable forms of phenotype (contractile, reversible synthetic, and irreversible synthetic). We compared the interactions of these three smooth muscle phenotypes with rabbit very low density lipoprotein (VLDL), low density lipoprotein (LDL), and very low density lipoprotein from cholesterol-fed rabbits (beta-VLDL). beta-VLDL showed saturable. high-affinity binding characteristics with each phenotype predominantly through the B/E receptor. The irreversible synthetic cells displayed the greatest binding capacity and the contractile cells, the least. Binding and degradation of normal VLDL was less than that of beta-VLDL and higher than that of LDL. Only the irreversible synthetic cells showed substantial (about threefold) cholesteryl ester formation and cholesterol accumulation, and then only when incubated with beta-VLDL. Substantial stainable lipid, shown chemically to include triglyceride, cholesterol and cholesteryl ester, was also observed only when irreversible synthetic cells were exposed to beta-VLDL. The high capacity of irreversible synthetic-state, smooth muscle cells to bind and accumulate beta-VLDL in contrast to the relative immunity of contractile cells may be relevant to the genesis of atherosclerosis in the rabbit and possibly also in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409956     DOI: 10.1161/01.atv.5.4.318

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  10 in total

1.  Characterization of a continuous smooth muscle cell line derived from rabbit aorta.

Authors:  M Nachtigal; M L Nagpal; P Greenspan; S A Nachtigal; A Legrand
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

2.  Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype.

Authors:  A H Ang; G Tachas; J H Campbell; J F Bateman; G R Campbell
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

3.  Mevalonate is essential for growth of porcine and human vascular smooth muscle cells in vitro.

Authors:  G Rogler; K J Lackner; G Schmitz
Journal:  Basic Res Cardiol       Date:  1995 Nov-Dec       Impact factor: 17.165

4.  A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions.

Authors:  O J Printseva; M M Peclo; A V Tjurmin; A I Faerman; S M Danilov; V S Repin; V N Smirnov
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Macrophages enhance binding of beta-VLDL and cholesterol ester accumulation in cultured aortic smooth muscle cells.

Authors:  R E Rennick; J H Campbell; G R Campbell
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

6.  Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits.

Authors:  Y Ishikawa; T Ishii; N Asuwa; S Masuda
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

7.  Expression of the cyclin-dependent kinase inhibitor, p21Waf-1/Cip-1/Sdi-1, in human vascular smooth muscle cells in the proliferating state.

Authors:  M Yamaguchi; S Kato; T Fujii; N Miyagi; M Morimatsu
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

8.  Lipid biosynthesis in cultured arterial smooth muscle cells is related to their phenotype.

Authors:  E Dusserre; M C Bourdillon; M Ciavatti; C Covacho; S Renaud
Journal:  Lipids       Date:  1993-07       Impact factor: 1.880

Review 9.  Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis.

Authors:  Lin Mao; Ruili Yin; Longyan Yang; Dong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

10.  Caveolin-3 Promotes a Vascular Smooth Muscle Contractile Phenotype.

Authors:  Jorge L Gutierrez-Pajares; Jeannette Iturrieta; Vipin Dulam; Yu Wang; Stephanos Pavlides; Gabriella Malacari; Michael P Lisanti; Philippe G Frank
Journal:  Front Cardiovasc Med       Date:  2015-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.